Benchling & uniQure: Bringing a gene therapy pioneer from paper to the cloud
Aug 24, 2021
uniQure is rapidly advancing a pipeline of AAV-based gene therapies to treat patients with hemophilia, Huntington’s disease, and other severe genetic diseases, but they needed a digital solution that could track their gene therapy workflows end-to-end and enable international collaboration. Learn how Benchling was able to move uniQure from paper to the cloud, improving R&D traceability and collaboration, and accelerating speed to innovation.
Benchling & uniQure Case Study.pdf